COMPASS THERAPEUTICS, INC. Tax Withholding Paid on Stock Awards
COMPASS THERAPEUTICS, INC. (CMPX) reported Tax Withholding Paid on Stock Awards of $489.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-06
- COMPASS THERAPEUTICS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $0.00.
- COMPASS THERAPEUTICS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $489.00K, a 40.00% decline year-over-year.
- COMPASS THERAPEUTICS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $212.00K, a 120.83% increase year-over-year.
- COMPASS THERAPEUTICS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $0.00.
- COMPASS THERAPEUTICS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $1.03M, a 342.67% increase from fiscal 2024.
- COMPASS THERAPEUTICS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $232.00K, a 45.91% increase from fiscal 2023.
- COMPASS THERAPEUTICS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $159.00K.
- COMPASS THERAPEUTICS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $0.00.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $489.00K 10-Q · filed 2026-08-06 | $701.00K derived: sum of 3 quarters · filed 2026-08-06 | $701.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $489.00K 10-Q · filed 2026-05-05 | $701.00K derived: sum of 2 quarters · filed 2026-05-05 | $701.00K derived: sum of 3 quarters · filed 2026-05-05 | $701.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $212.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $212.00K derived: sum of 2 quarters · filed 2026-03-05 | $212.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.03M 10-K · filed 2026-03-05 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | $815.00K 10-Q · filed 2025-11-05 | $911.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $815.00K 10-Q · filed 2026-08-06 | $911.00K derived: sum of 3 quarters · filed 2026-08-06 | $911.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $815.00K 10-Q · filed 2026-05-05 | $911.00K derived: sum of 2 quarters · filed 2026-05-05 | $911.00K derived: sum of 3 quarters · filed 2026-05-05 | $911.00K derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $96.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $96.00K derived: sum of 2 quarters · filed 2026-03-05 | $96.00K derived: sum of 3 quarters · filed 2026-03-05 | $232.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $136.00K 10-Q · filed 2025-11-05 | $295.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $136.00K 10-Q · filed 2025-08-11 | $295.00K derived: sum of 3 quarters · filed 2025-08-11 | $295.00K derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $136.00K 10-Q · filed 2025-05-08 | $295.00K derived: sum of 2 quarters · filed 2025-05-08 | $295.00K derived: sum of 3 quarters · filed 2025-05-08 | $295.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $159.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $159.00K derived: sum of 2 quarters · filed 2025-02-27 | $159.00K derived: sum of 3 quarters · filed 2025-02-27 | $159.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $0.00 10-Q · filed 2024-08-12 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-13 | |||
| 2022-12-31 | $0.00 10-K · filed 2024-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |